Last 12 months
Inside the activity.
5 purchase rows · 2 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 1 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 2 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 4 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 18, 2026 Filed Feb 20, 2026 00:30 UTC |
RADEMACHER JOHN CHARLESDirector · Chief Executive Officer
|
GrantCommon Stock | 78,876 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-26-004774 · rdgdoc.xml · nonDerivative · entry 1 RADEMACHER JOHN CHARLES · CIK 0001779969 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 831,057 F1 · shares: The restricted stock units granted in this award vest as to one third of the underlying shares of common stock on each of the first, second, and third anniversary of the grant date. Read SEC document |
| February 18, 2026 Filed Feb 20, 2026 00:30 UTC |
Adewunmi FemiChief Medical Officer
|
GrantCommon Stock | 9,579 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-26-004773 · rdgdoc.xml · nonDerivative · entry 1 Adewunmi Femi · CIK 0002020079 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,337 F1 · shares: The restricted stock units granted in this award vest as to one third of the underlying shares of common stock on each of the first, second, and third anniversary of the grant date. Read SEC document |
| February 18, 2026 Filed Feb 20, 2026 00:25 UTC |
Sethna MeenalChief Financial Officer
|
GrantCommon Stock | 27,045 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-26-004772 · rdgdoc.xml · nonDerivative · entry 1 Sethna Meenal · CIK 0001643464 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 82,112 F1 · shares: The restricted stock units granted in this award vest as to one third of the underlying shares of common stock on each of the first, second, and third anniversary of the grant date. Read SEC document |
| February 18, 2026 Filed Feb 20, 2026 00:25 UTC |
Smyser CollinGC & Corporate Secretary
|
GrantCommon Stock | 15,213 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-26-004771 · rdgdoc.xml · nonDerivative · entry 1 Smyser Collin · CIK 0001924779 · GC & Corporate Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 94,215 F1 · shares: The restricted stock units granted in this award vest as to one third of the underlying shares of common stock on each of the first, second, and third anniversary of the grant date. Read SEC document |
| February 17, 2026 Filed Feb 20, 2026 01:02 UTC |
Whitworth LukeChief Operating Officer
|
Tax withholdingCommon Stock | 508 | $35.24 | $17,901.92 |
DisclosureSEC source: 0001437749-26-004781 · rdgdoc.xml · nonDerivative · entry 1 Whitworth Luke · CIK 0001961976 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 171,815 Read SEC document |
| February 17, 2026 Filed Feb 20, 2026 01:02 UTC |
Grashoff Christopher L.Chief Growth Officer
|
Tax withholdingCommon Stock | 259 | $35.24 | $9,127.16 |
DisclosureSEC source: 0001437749-26-004780 · rdgdoc.xml · nonDerivative · entry 1 Grashoff Christopher L. · CIK 0002004149 · Chief Growth Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,880 Read SEC document |
| February 17, 2026 Filed Feb 20, 2026 01:01 UTC |
Bavaro MichaelChief Human Resources Officer
|
Tax withholdingCommon Stock | 551 | $35.24 | $19,417.24 |
DisclosureSEC source: 0001437749-26-004779 · rdgdoc.xml · nonDerivative · entry 1 Bavaro Michael · CIK 0001961988 · Chief Human Resources Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 44,423 Read SEC document |
| February 17, 2026 Filed Feb 20, 2026 01:00 UTC |
Maggio NicoleChief Accounting Officer
|
Tax withholdingCommon Stock | 247 | $35.24 | $8,704.28 |
DisclosureSEC source: 0001437749-26-004778 · rdgdoc.xml · nonDerivative · entry 1 Maggio Nicole · CIK 0002032392 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,229 Read SEC document |
| November 03, 2025 Filed Nov 4, 2025 21:30 UTC |
KRAEMER HARRY M JANSEN JRDirector
|
PurchaseCommon Stock | 38,000 | $25.98 | $987,392.00 |
DisclosureSEC source: 0001437749-25-033040 · rdgdoc.xml · nonDerivative · entry 1 KRAEMER HARRY M JANSEN JR · CIK 0001082877 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 413,390 F1 · price: Reflects the weighted average price of 38,000 shares of common stock of Option Care Health, Inc. purchased by the reporting person in multiple transactions on November 3, 2025 with purchase prices ranging from $25.835 to $26.235 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price. Read SEC document |
| October 01, 2025 Filed Oct 3, 2025 20:15 UTC |
Sethna MeenalChief Financial Officer
|
GrantCommon Stock | 55,067 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-25-030477 · rdgdoc.xml · nonDerivative · entry 1 Sethna Meenal · CIK 0001643464 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 55,067 F1 · shares: The restricted stock units granted in this award vest on the third anniversary of the grant date. Read SEC document |
| September 09, 2025 Filed Sep 10, 2025 20:18 UTC |
Wright Norman L.Director
|
PurchaseCommon Stock | 3,411 | $29.31 | $99,976.07 |
DisclosureSEC source: 0001437749-25-028768 · rdgdoc.xml · nonDerivative · entry 1 Wright Norman L. · CIK 0001933103 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,501 F1 · price: Reflects the weighted average price of 3,411 shares of common stock of Option Care Health, Inc. purchased by the reporting person in multiple transactions on September 9, 2025 with purchase prices ranging from $29.28 to $29.31 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price. Read SEC document |
| August 21, 2025 Filed Aug 21, 2025 22:24 UTC |
SULLIVAN TIMOTHY PDirector
|
PurchaseCommon Stock | 20,000 | $27.51 | $550,200.00 |
DisclosureSEC source: 0001437749-25-027535 · rdgdoc.xml · nonDerivative · entry 1 SULLIVAN TIMOTHY P · CIK 0001245970 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 49,229 Read SEC document |
| August 21, 2025 Filed Aug 21, 2025 22:24 UTC |
GOLDING DAVID WDirector
|
PurchaseCommon Stock | 1,000 | $27.63 | $27,625.00 |
DisclosureSEC source: 0001437749-25-027534 · rdgdoc.xml · nonDerivative · entry 1 GOLDING DAVID W · CIK 0001286630 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 116,525 Read SEC document |
| August 20, 2025 Filed Aug 21, 2025 22:26 UTC |
Pate R CarterDirector
|
PurchaseCommon Stock | 750 | $27.19 | $20,391.45 |
DisclosureSEC source: 0001437749-25-027538 · rdgdoc.xml · nonDerivative · entry 1 Pate R Carter · CIK 0001641406 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 41,910 F1 · price: Reflects the weighted average price of 750 shares of common stock of Option Care Health, Inc. purchased by the reporting person in multiple transactions on August 20, 2025 with purchase prices ranging from $27.18 to $27.1899 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price. Read SEC document |
| August 20, 2025 Filed Aug 21, 2025 22:25 UTC |
KRAEMER HARRY M JANSEN JRDirector
|
PurchaseCommon Stock | 36,000 | $27.15 | $977,277.60 |
DisclosureSEC source: 0001437749-25-027536 · rdgdoc.xml · nonDerivative · entry 1 KRAEMER HARRY M JANSEN JR · CIK 0001082877 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 375,390 F1 · price: Reflects the weighted average price of 36,000 shares of common stock of Option Care Health, Inc. purchased by the reporting person in multiple transactions on August 20, 2025 with purchase prices ranging from $26.92 to $27.20 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price. Read SEC document |
| August 06, 2025 Filed Aug 8, 2025 20:23 UTC |
Maggio NicoleChief Accounting Officer
|
GrantCommon Stock | 7,167 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-25-025729 · rdgdoc.xml · nonDerivative · entry 1 Maggio Nicole · CIK 0002032392 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,476 F1 · shares: The restricted stock units granted in this award vest in full on August 6, 2027. Read SEC document |
| May 19, 2025 Filed May 21, 2025 20:17 UTC |
Smyser CollinGC & Corporate Secretary
|
Exercise / conversionRestricted Stock Unit · Derivative | 10,384 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-25-017987 · rdgdoc.xml · derivative · entry 6 Smyser Collin · CIK 0001924779 · GC & Corporate Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,384 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Common Stock. F3 · derivative.exercise_date: All restricted stock units granted in this award vested on May 19, 2025. F3 · derivative.expiration_date: All restricted stock units granted in this award vested on May 19, 2025. Read SEC document |
| May 19, 2025 Filed May 21, 2025 20:17 UTC |
Smyser CollinGC & Corporate Secretary
|
Exercise / conversionRestricted Stock Unit · Derivative | 812 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-25-017987 · rdgdoc.xml · derivative · entry 5 Smyser Collin · CIK 0001924779 · GC & Corporate Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 812 Underlying: Common Stock · 812 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Common Stock. F2 · derivative.exercise_date: All restricted stock units granted in this award vest as to 25% of the underlying shares of Common Stock on each of the first, second, third and fourth anniversaries of the grant date. F2 · derivative.expiration_date: All restricted stock units granted in this award vest as to 25% of the underlying shares of Common Stock on each of the first, second, third and fourth anniversaries of the grant date. Read SEC document |
| May 19, 2025 Filed May 21, 2025 20:17 UTC |
Smyser CollinGC & Corporate Secretary
|
Tax withholdingCommon Stock | 10,713 | $33.09 | $354,493.17 |
DisclosureSEC source: 0001437749-25-017987 · rdgdoc.xml · nonDerivative · entry 3 Smyser Collin · CIK 0001924779 · GC & Corporate Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 79,002 Read SEC document |
| May 19, 2025 Filed May 21, 2025 20:17 UTC |
Smyser CollinGC & Corporate Secretary
|
Exercise / conversionCommon Stock | 10,384 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-25-017987 · rdgdoc.xml · nonDerivative · entry 2 Smyser Collin · CIK 0001924779 · GC & Corporate Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 89,715 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 19, 2025 Filed May 21, 2025 20:17 UTC |
Smyser CollinGC & Corporate Secretary
|
Exercise / conversionCommon Stock | 812 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-25-017987 · rdgdoc.xml · nonDerivative · entry 1 Smyser Collin · CIK 0001924779 · GC & Corporate Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 79,331 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 14, 2025 Filed May 19, 2025 22:28 UTC |
BETTEN ELIZABETH QUADROSDirector
|
GrantCommon Stock | 5,034 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-25-017676 · rdgdoc.xml · nonDerivative · entry 1 BETTEN ELIZABETH QUADROS · CIK 0001780016 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,373 F1 · shares: The reporting person received an award of restricted stock units on May 14, 2025, which vest in equal installments on each of the first, second and third anniversaries of the grant date. The number of restricted stock units granted was calculated to reflect $160,000 of value based on the closing price of the issuer's common stock on May 14, 2025. Read SEC document |
| May 14, 2025 Filed May 19, 2025 22:28 UTC |
Bierbower Elizabeth DDirector
|
GrantCommon Stock | 5,034 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-25-017675 · rdgdoc.xml · nonDerivative · entry 1 Bierbower Elizabeth D · CIK 0001561149 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,874 F1 · shares: The reporting person received an award of restricted stock units on May 14, 2025, which vest in equal installments on each of the first, second and third anniversaries of the grant date. The number of restricted stock units granted was calculated to reflect $160,000 of value based on the closing price of the issuer's common stock on May 14, 2025. Read SEC document |
| May 14, 2025 Filed May 19, 2025 22:27 UTC |
Deckmann NatashaDirector
|
GrantCommon Stock | 627 | $31.79 | $19,932.33 |
DisclosureSEC source: 0001437749-25-017674 · rdgdoc.xml · nonDerivative · entry 2 Deckmann Natasha · CIK 0001902330 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,161 F2 · shares: The reporting person received restricted stock units on May 14, 2025 in lieu of cash retainer payments, which vest in equal installments on each of the first, second and third anniversaries of the grant date. The number of restricted stock units granted was calculated to reflect the amount of cash fees received in the form of restricted stock units based on the closing price of the issuer's common stock on May 14, 2025. Read SEC document |
| May 14, 2025 Filed May 19, 2025 22:27 UTC |
Deckmann NatashaDirector
|
GrantCommon Stock | 5,034 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-25-017674 · rdgdoc.xml · nonDerivative · entry 1 Deckmann Natasha · CIK 0001902330 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,534 F1 · shares: The reporting person received an award of restricted stock units on May 14, 2025, which vest in equal installments on each of the first, second and third anniversaries of the grant date. The number of restricted stock units granted was calculated to reflect $160,000 of value based on the closing price of the issuer's common stock on May 14, 2025. Read SEC document |
| May 14, 2025 Filed May 19, 2025 22:27 UTC |
GOLDING DAVID WDirector
|
GrantCommon Stock | 3,381 | $31.79 | $107,481.99 |
DisclosureSEC source: 0001437749-25-017673 · rdgdoc.xml · nonDerivative · entry 2 GOLDING DAVID W · CIK 0001286630 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 115,525 F2 · shares: The reporting person received restricted stock units on May 14, 2025 in lieu of cash retainer payments, which vest in equal installments on each of the first, second and third anniversaries of the grant date. The number of restricted stock units granted was calculated to reflect the amount of cash fees received in the form of restricted stock units based on the closing price of the issuer's common stock on May 14, 2025. Read SEC document |
| May 14, 2025 Filed May 19, 2025 22:27 UTC |
GOLDING DAVID WDirector
|
GrantCommon Stock | 5,034 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-25-017673 · rdgdoc.xml · nonDerivative · entry 1 GOLDING DAVID W · CIK 0001286630 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 112,144 F1 · shares: The reporting person received an award of restricted stock units on May 14, 2025, which vest in equal installments on each of the first, second and third anniversaries of the grant date. The number of restricted stock units granted was calculated to reflect $160,000 of value based on the closing price of the issuer's common stock on May 14, 2025. Read SEC document |
| May 14, 2025 Filed May 19, 2025 22:26 UTC |
KRAEMER HARRY M JANSEN JRDirector
|
GrantCommon Stock | 8,022 | $31.79 | $255,019.38 |
DisclosureSEC source: 0001437749-25-017672 · rdgdoc.xml · nonDerivative · entry 2 KRAEMER HARRY M JANSEN JR · CIK 0001082877 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 339,390 F2 · shares: The reporting person received restricted stock units on May 14, 2025 in lieu of cash retainer payments, which vest in equal installments on each of the first, second and third anniversaries of the grant date. The number of restricted stock units granted was calculated to reflect the amount of cash fees received in the form of restricted stock units based on the closing price of the issuer's common stock on May 14, 2025. Read SEC document |
| May 14, 2025 Filed May 19, 2025 22:26 UTC |
KRAEMER HARRY M JANSEN JRDirector
|
GrantCommon Stock | 5,034 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-25-017672 · rdgdoc.xml · nonDerivative · entry 1 KRAEMER HARRY M JANSEN JR · CIK 0001082877 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 331,368 F1 · shares: The reporting person received an award of restricted stock units on May 14, 2025, which vest in equal installments on each of the first, second and third anniversaries of the grant date. The number of restricted stock units granted was calculated to reflect $160,000 of value based on the closing price of the issuer's common stock on May 14, 2025. Read SEC document |
| May 14, 2025 Filed May 19, 2025 22:26 UTC |
Pate R CarterDirector
|
GrantCommon Stock | 5,034 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-25-017671 · rdgdoc.xml · nonDerivative · entry 1 Pate R Carter · CIK 0001641406 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 41,160 F1 · shares: The reporting person received an award of restricted stock units on May 14, 2025, which vest in equal installments on each of the first, second and third anniversaries of the grant date. The number of restricted stock units granted was calculated to reflect $160,000 of value based on the closing price of the issuer's common stock on May 14, 2025. Read SEC document |
| May 14, 2025 Filed May 19, 2025 22:25 UTC |
SULLIVAN TIMOTHY PDirector
|
GrantCommon Stock | 3,381 | $31.79 | $107,481.99 |
DisclosureSEC source: 0001437749-25-017670 · rdgdoc.xml · nonDerivative · entry 2 SULLIVAN TIMOTHY P · CIK 0001245970 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,229 F2 · shares: The reporting person received restricted stock units on May 14, 2025 in lieu of cash retainer payments, which vest in equal installments on each of the first, second and third anniversaries of the grant date. The number of restricted stock units granted was calculated to reflect the amount of cash fees received in the form of restricted stock units based on the closing price of the issuer's common stock on May 14, 2025. Read SEC document |
| May 14, 2025 Filed May 19, 2025 22:25 UTC |
SULLIVAN TIMOTHY PDirector
|
GrantCommon Stock | 5,034 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-25-017670 · rdgdoc.xml · nonDerivative · entry 1 SULLIVAN TIMOTHY P · CIK 0001245970 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,848 F1 · shares: The reporting person received an award of restricted stock units on May 14, 2025, which vest in equal installments on each of the first, second and third anniversaries of the grant date. The number of restricted stock units granted was calculated to reflect $160,000 of value based on the closing price of the issuer's common stock on May 14, 2025. Read SEC document |
| May 14, 2025 Filed May 19, 2025 22:25 UTC |
Bodem Barbara W.Director
|
GrantCommon Stock | 5,034 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-25-017669 · rdgdoc.xml · nonDerivative · entry 1 Bodem Barbara W. · CIK 0001713893 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,090 F1 · shares: The reporting person received an award of restricted stock units on May 14, 2025, which vest in equal installments on each of the first, second and third anniversaries of the grant date. The number of restricted stock units granted was calculated to reflect $160,000 of value based on the closing price of the issuer's common stock on May 14, 2025. Read SEC document |
| May 14, 2025 Filed May 19, 2025 22:23 UTC |
Wright Norman L.Director
|
GrantCommon Stock | 5,034 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-25-017668 · rdgdoc.xml · nonDerivative · entry 1 Wright Norman L. · CIK 0001933103 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,090 F1 · shares: The reporting person received an award of restricted stock units on May 14, 2025, which vest in equal installments on each of the first, second and third anniversaries of the grant date. The number of restricted stock units granted was calculated to reflect $160,000 of value based on the closing price of the issuer's common stock on May 14, 2025. Read SEC document |
| May 14, 2025 Filed May 19, 2025 22:23 UTC |
BRANDT ERICDirector
|
GrantCommon Stock | 5,034 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-25-017667 · rdgdoc.xml · nonDerivative · entry 1 BRANDT ERIC · CIK 0001190639 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,359 F1 · shares: The reporting person received an award of restricted stock units on May 14, 2025, which vest in equal installments on each of the first, second and third anniversaries of the grant date. The number of restricted stock units granted was calculated to reflect $160,000 of value based on the closing price of the issuer's common stock on May 14, 2025. Read SEC document |
| April 22, 2025 Filed Apr 24, 2025 21:01 UTC |
Adewunmi FemiChief Medical Officer
|
Tax withholdingCommon Stock | 1,396 | $31.54 | $44,029.84 |
DisclosureSEC source: 0001437749-25-012987 · rdgdoc.xml · nonDerivative · entry 1 Adewunmi Femi · CIK 0002020079 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,758 Read SEC document |
| February 28, 2025 Filed Mar 3, 2025 22:52 UTC |
Bavaro MichaelChief Human Resources Officer
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 2,386 | $0.00 Strike: $28.86 | $0.00 |
DisclosureSEC source: 0001437749-25-005968 · rdgdoc.xml · derivative · entry 9 Bavaro Michael · CIK 0001961988 · Chief Human Resources Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,772 Underlying: Common Stock · 2,386 shares Expires 2033-02-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Stock options that vest as to 25% of the underlying shares of Common Stock on each of the first, second, third and fourth anniversaries of the grant date. Read SEC document |
| February 28, 2025 Filed Mar 3, 2025 22:52 UTC |
Bavaro MichaelChief Human Resources Officer
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 2,153 | $0.00 Strike: $23.96 | $0.00 |
DisclosureSEC source: 0001437749-25-005968 · rdgdoc.xml · derivative · entry 8 Bavaro Michael · CIK 0001961988 · Chief Human Resources Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,153 Underlying: Common Stock · 2,153 shares Expires 2032-02-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Stock options that vest as to 25% of the underlying shares of Common Stock on each of February 17, 2023, February 17, 2024, February 17, 2025 and February 17, 2026. Read SEC document |
| February 28, 2025 Filed Mar 3, 2025 22:52 UTC |
Bavaro MichaelChief Human Resources Officer
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 8,974 | $0.00 Strike: $25.75 | $0.00 |
DisclosureSEC source: 0001437749-25-005968 · rdgdoc.xml · derivative · entry 7 Bavaro Michael · CIK 0001961988 · Chief Human Resources Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 8,974 shares Expires 2031-10-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Fully vested. Read SEC document |
| February 28, 2025 Filed Mar 3, 2025 22:52 UTC |
Bavaro MichaelChief Human Resources Officer
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 1,226 | $0.00 Strike: $18.97 | $0.00 |
DisclosureSEC source: 0001437749-25-005968 · rdgdoc.xml · derivative · entry 6 Bavaro Michael · CIK 0001961988 · Chief Human Resources Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,226 shares Expires 2031-02-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Fully vested. Read SEC document |
| February 28, 2025 Filed Mar 3, 2025 22:52 UTC |
Bavaro MichaelChief Human Resources Officer
|
SaleCommon Stock | 30,996 | $33.26 | $1,030,843.27 |
DisclosureSEC source: 0001437749-25-005968 · rdgdoc.xml · nonDerivative · entry 5 Bavaro Michael · CIK 0001961988 · Chief Human Resources Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 44,974 F1 · price: Reflects the weighted average price of 30,996 shares of common stock of Option Care Health, Inc. sold by the reporting person in multiple transactions on February 28, 2025 with sale prices ranging from $33.25 to $33.285 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| February 28, 2025 Filed Mar 3, 2025 22:52 UTC |
Bavaro MichaelChief Human Resources Officer
|
Exercise / conversionCommon Stock | 2,386 | $28.86 | $68,859.96 |
DisclosureSEC source: 0001437749-25-005968 · rdgdoc.xml · nonDerivative · entry 4 Bavaro Michael · CIK 0001961988 · Chief Human Resources Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 75,970 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 28, 2025 Filed Mar 3, 2025 22:52 UTC |
Bavaro MichaelChief Human Resources Officer
|
Exercise / conversionCommon Stock | 2,153 | $23.96 | $51,585.88 |
DisclosureSEC source: 0001437749-25-005968 · rdgdoc.xml · nonDerivative · entry 3 Bavaro Michael · CIK 0001961988 · Chief Human Resources Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 73,584 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 28, 2025 Filed Mar 3, 2025 22:52 UTC |
Bavaro MichaelChief Human Resources Officer
|
Exercise / conversionCommon Stock | 8,974 | $25.75 | $231,080.50 |
DisclosureSEC source: 0001437749-25-005968 · rdgdoc.xml · nonDerivative · entry 2 Bavaro Michael · CIK 0001961988 · Chief Human Resources Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 71,431 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 28, 2025 Filed Mar 3, 2025 22:52 UTC |
Bavaro MichaelChief Human Resources Officer
|
Exercise / conversionCommon Stock | 1,226 | $18.97 | $23,257.22 |
DisclosureSEC source: 0001437749-25-005968 · rdgdoc.xml · nonDerivative · entry 1 Bavaro Michael · CIK 0001961988 · Chief Human Resources Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 62,457 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 24, 2025 Filed Feb 27, 2025 00:40 UTC |
RADEMACHER JOHN CHARLESDirector · Chief Executive Officer
|
GrantCommon Stock | 74,814 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-25-005307 · rdgdoc.xml · nonDerivative · entry 1 RADEMACHER JOHN CHARLES · CIK 0001779969 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 752,181 F1 · shares: The restricted stock units granted in this award vest as to one third of the underlying shares of common stock on each of the first, second, and third anniversary of the grant date. Read SEC document |
| February 24, 2025 Filed Feb 27, 2025 00:40 UTC |
Adewunmi FemiChief Medical Officer
|
GrantCommon Stock | 10,287 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-25-005306 · rdgdoc.xml · nonDerivative · entry 1 Adewunmi Femi · CIK 0002020079 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,154 F1 · shares: The restricted stock units granted in this award vest as to one third of the underlying shares of common stock on each of the first, second, and third anniversary of the grant date. Read SEC document |
| February 24, 2025 Filed Feb 27, 2025 00:39 UTC |
Bavaro MichaelChief Human Resources Officer
|
GrantCommon Stock | 10,599 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-25-005305 · rdgdoc.xml · nonDerivative · entry 1 Bavaro Michael · CIK 0001961988 · Chief Human Resources Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 61,231 F1 · shares: The restricted stock units granted in this award vest as to one third of the underlying shares of common stock on each of the first, second, and third anniversary of the grant date. Read SEC document |
| February 24, 2025 Filed Feb 27, 2025 00:39 UTC |
Grashoff Christopher L.Chief Growth Officer
|
GrantCommon Stock | 13,404 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-25-005304 · rdgdoc.xml · nonDerivative · entry 1 Grashoff Christopher L. · CIK 0002004149 · Chief Growth Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,139 F1 · shares: The restricted stock units granted in this award vest as to one third of the underlying shares of common stock on each of the first, second, and third anniversary of the grant date. Read SEC document |
| February 24, 2025 Filed Feb 27, 2025 00:38 UTC |
SHAPIRO MICHAEL H.Chief Financial Officer
|
GrantCommon Stock | 31,173 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-25-005303 · rdgdoc.xml · nonDerivative · entry 1 SHAPIRO MICHAEL H. · CIK 0001524881 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 311,933 F1 · shares: The restricted stock units granted in this award vest as to one third of the underlying shares of common stock on each of the first, second, and third anniversary of the grant date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.